News Your Pediatric AD Patients Can Use: Roflumilast Cream 0.05% Now Available in Pharmacies Across the US
Roflumilast cream 0.05% (Zoryve, Arcutis) is now commercially available in pharmacies for the treatment of mild-to-moderate atopic dermatitis (AD) in children ages 2 to 5 in the United States. The product is being reviewed by commercial pharmacy benefit managers and other plans to enable similar coverage as the entire roflumilast portfolio. On October 6, 2025, […]